{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:59:39Z","timestamp":1774310379115,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Liver transplant recipients face high risks of cardiometabolic events after transplant, driven by posttransplant weight gain, diabetes, hypertension, as well as immunosuppression-related side effects. Glucagon-like peptide-1 receptor agonists (GLP1RAs) improve metabolic and cardiorenal outcomes in nontransplant populations, but their role in liver transplant recipients remains understudied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>This retrospective cohort study used TriNetX data (January 2010\u2013December 2023) to compare outcomes in liver transplant recipients prescribed GLP1RAs (semaglutide, dulaglutide, liraglutide) within 1-mo posttransplant (n\u2005=\u2005546) versus nonusers (n\u2005=\u200537 153). Propensity score matching (1:1) balanced demographics, comorbidities, and medications (n\u2005=\u2005541 per group). Outcomes included mortality, hospitalizations, cardiovascular\/renal\/respiratory events, and graft outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Over a mean follow-up 838.5 d (SD 291.9) in the GLP1RA cohort and 884.3 d (SD 313.7) in the non-GLP1RA group, GLP1RA use was associated with a 43% lower all-cause mortality (7.0% versus 12.9%; hazard ratio [HR], 0.566; 95% confidence interval [CI], 0.381-0.841) and 39% fewer hospitalizations (60.4% versus 74.5%; HR, 0.613; 95% CI, 0.530-0.710). Acute heart failure (HR, 0.386; 95% CI, 0.285-0.524), renal failure\/dialysis (HR, 0.489; 95% CI, 0.413-0.579), and respiratory failure (HR, 0.484; 95% CI, 354-0.662) risks were significantly reduced. No differences were observed in graft failure\/rejection, myocardial infarction, stroke, atrial fibrillation\/flutter, ventricular tachycardia, or ischemic optic neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Early GLP1RA initiation in liver transplant recipients was associated with reduced mortality, hospitalizations, respiratory, and cardiorenal complications without compromising graft safety. These findings support GLP1RAs as a promising adjunct therapy, warranting prospective trials to confirm benefits in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001932","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:00:12Z","timestamp":1774306812000},"page":"e1932","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study"],"prefix":"10.1097","volume":"12","author":[{"given":"Hesham","family":"Sheashaa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-9513","authenticated-orcid":false,"given":"Ramzi","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Elshaer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Nhat","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, MN."},{"name":"Department of Medicine, University of Arizona, Tucson, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Mouhaffel","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Arizona, Tucson, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiad","family":"Habib","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Abdelnabi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Lester","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Simper","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Alsidawi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Steidley","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashar A.","family":"Aqel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ."},{"name":"Department of Medicine, Transplant Center, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Barnhill","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ."},{"name":"Department of Medicine, Transplant Center, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ray","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ."},{"name":"Department of Medicine, Transplant Center, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadi","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Arsanjani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"R1-20260323","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges.","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep"},{"key":"R2-20260323","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/tri.13308","article-title":"New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.","volume":"31","author":"Beckmann","year":"2018","journal-title":"Transpl Int"},{"key":"R3-20260323","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e31826e592e","article-title":"Calcineurin inhibition and new-onset diabetes mellitus after transplantation.","volume":"95","author":"Chakkera","year":"2013","journal-title":"Transplantation"},{"key":"R4-20260323","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents.","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"R5-20260323","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/liv.12133","article-title":"Calcineurin inhibitors in liver transplantation\u2014still champions or threatened by serious competitors?","volume":"33","author":"Beckebaum","year":"2013","journal-title":"Liver Int"},{"key":"R6-20260323","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3748\/wjg.v26.i21.2740","article-title":"Post-transplant diabetes mellitus and preexisting liver disease\u2014a bidirectional relationship affecting treatment and management.","volume":"26","author":"Cigrovski Berkovic","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R7-20260323","doi-asserted-by":"crossref","first-page":"1293926","DOI":"10.3389\/fcdhc.2023.1293926","article-title":"The benefits of GLP1 receptors in cardiovascular diseases.","volume":"4","author":"Ferhatbegovic","year":"2023","journal-title":"Front Clin Diabetes Healthc"},{"key":"R8-20260323","doi-asserted-by":"crossref","first-page":"1223169","DOI":"10.3389\/frtra.2023.1223169","article-title":"Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis.","volume":"2","author":"Atthota","year":"2023","journal-title":"Front Transplant"},{"key":"R9-20260323","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jceh.2022.06.007","article-title":"Immunosuppressive drugs in liver transplant: an insight.","volume":"12","author":"Panackel","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R10-20260323","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide.","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R11-20260323","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/TP.0000000000004945","article-title":"Glucagon-like peptide 1 receptor agonists and cardiovascular outcomes in solid organ transplant recipients with diabetes mellitus.","volume":"108","author":"Dotan","year":"2024","journal-title":"Transplantation"},{"key":"R12-20260323","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12933-025-02649-0","article-title":"Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients.","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R13-20260323","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cardfail.2025.01.022","article-title":"Efficacy of GLP-1 receptor agonists in patients with heart failure and mildly reduced or preserved ejection fraction: a systematic review and meta-analysis.","volume":"31","author":"Waqas","year":"2025","journal-title":"J Card Fail"},{"key":"R14-20260323","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R15-20260323","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/medicina55060233","article-title":"GLP-1 receptor agonists and kidney protection.","volume":"55","author":"Greco","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R16-20260323","doi-asserted-by":"crossref","first-page":"1586941","DOI":"10.3389\/fendo.2025.1586941","article-title":"Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors.","volume":"16","author":"Grancini","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R17-20260323","doi-asserted-by":"crossref","first-page":"e15401","DOI":"10.1111\/ctr.15401","article-title":"Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 receptor agonists after heart transplantation.","volume":"38","author":"Donald","year":"2024","journal-title":"Clin Transplant"},{"key":"R18-20260323","article-title":"GLP-1 receptor agonists for kidney transplant recipients.","author":"Schmitz","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20260323","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule.","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:00:18Z","timestamp":1774306818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001932","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"2025-12-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}